Sentinel lymph node status in patients with locally advanced cervical cancers and impact of neoadjuvant chemotherapy

Gynecologic Oncology

Volumn 125, Issue 2, 2012, Pages 303-306

  Slama, J ^a   Dundr, P ^a   Dusek, L ^b   Fischerova, D ^a   Pinkavova, I ^a   Zikan, M ^a   Vrzackova, P ^a   Kojanova, M ^a   Cibula, D ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Cervical cancer; Neoadjuvant chemotherapy; Radical hysterectomy; Sentinel lymph node

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MACROMETASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR VOLUME; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RETROSPECTIVE STUDIES; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84859585314     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.02.010     Document Type: Article

References (16)

1. Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomised study. J Clin Oncol 2002;20:179-88. (Pubitemid 34032610)
2. Lissoni AA, Colombo N, Pellegrino A, Parma G, Zola P, Katsaros D, et al. A phase II, randomised trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patiens with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol 2009;20:660-5.
3. Colombo N, Peiretti M. Critical review of neoadjuvant chemotherapy followed by surgery for locally advanced cervical cancer. Int J Gynecol Cancer 2010;20:S47-8.
4. Zanetta G, Colombo A, Milani R, Placa F, Mangioni C. Long-term result of sequential postoperative treatment with vincristine, bleomycin, mitomycin-c, cisplatin and radiotherapy after surgery for high-risk patients with cervical carcinoma stage IB-IIA. Int J Gynecol Cancer 1995;5:40-4.
5. Gortzak-Uzan L, Jimenez W, Nofech-Mozes S, Ismiil N, Khalifa MA, Dubé V, et al. Sentinel node biopsy vs. pelvic lymphadenctomy in early stage cervical cancer: is it time to change the gold standard? Gynecol Oncol 2010;116:28-32.
6. Cibula D, Kuzel D, Slama J, Fischerova D, Dundr P, Freitag P, et al. Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer. Gynecol Oncol 2009;115:46-50.
7. Eifel PJ, MorrisM,Wharton JT,OswaldMJ. The influence of tumour size andmorphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994;29:9-16. (Pubitemid 24138859)
8. Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA) Collaboration. Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Database Syst Rev 2004:CD001774.
9. Sakuragi N, Satoh C, Takeda N, Hareyama H, TakedaM, Yamamoto R, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patiens with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 1999;85:1547-54. (Pubitemid 29152827)
10. Euscher ED, Malpica A, Atkinson EN, Levenback CF, Frumovitz M, Deavers MT. Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. Am J Surg Pathol 2008;32:1336-43.
11. Levenback CF, van der Zee AGJ, Rob L, PlanteM, Covens A, Schneider A, et al. Sentinel lymph node biopsy in patients with gynecologic cancers. Expert panel statement from the International Sentinel Node Meeting, February 21, 2008. Gynecol Oncol 2009;114:151-6.
12. O'Boyle JD, Coleman RL, Bernstein SG, Lifshitz S,Muller CY, Miller DS. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study. Gynecol Oncol 2000;79:238-43.
13. Wydra D, Sawicki S, Wojtylak S, Bandurski T, Emerich J. Sentinel node identification in cervical cancer patients undergoing transperitoneal radical hysterectomy: a study of 100 cases. Int J Gynecol Cancer 2006;16:649-54.
14. Barranger E, Cortez A, Grahek D, Callard P, Uzan S, Darai E. Laparoscopic sentinel node procedure for cervical cancer: impact of neodjuvant chemoradiotherapy. Ann Surg Oncol 2004;11:445-52. (Pubitemid 40486757)
15. Rob L, Strnad P, Robova H, Charvat M, Pluta M, Schlegerova D, et al. Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. Gynecol Oncol 2005;98:281-8. (Pubitemid 41019117)
16. Cibula D, Abu-Rustum NR, Dusek L, Zikán M, Zaal A, Sevcik L, et al. Prognostic signifikance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol 2011;25:in print.